BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 35262262)

  • 1. "Reframing" dopamine signaling at the intersection of glial networks in the aged Parkinsonian brain as innate Nrf2/Wnt driver: Therapeutical implications.
    Marchetti B; Giachino C; Tirolo C; Serapide MF
    Aging Cell; 2022 Apr; 21(4):e13575. PubMed ID: 35262262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nrf2/Wnt resilience orchestrates rejuvenation of glia-neuron dialogue in Parkinson's disease.
    Marchetti B
    Redox Biol; 2020 Sep; 36():101664. PubMed ID: 32863224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt/β-catenin signaling is required to rescue midbrain dopaminergic progenitors and promote neurorepair in ageing mouse model of Parkinson's disease.
    L'Episcopo F; Tirolo C; Testa N; Caniglia S; Morale MC; Serapide MF; Pluchino S; Marchetti B
    Stem Cells; 2014 Aug; 32(8):2147-63. PubMed ID: 24648001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglia Polarization, Gene-Environment Interactions and Wnt/β-Catenin Signaling: Emerging Roles of Glia-Neuron and Glia-Stem/Neuroprogenitor Crosstalk for Dopaminergic Neurorestoration in Aged Parkinsonian Brain.
    L'Episcopo F; Tirolo C; Serapide MF; Caniglia S; Testa N; Leggio L; Vivarelli S; Iraci N; Pluchino S; Marchetti B
    Front Aging Neurosci; 2018; 10():12. PubMed ID: 29483868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Wnt1 regulated Frizzled-1/β-Catenin signaling pathway as a candidate regulatory circuit controlling mesencephalic dopaminergic neuron-astrocyte crosstalk: Therapeutical relevance for neuron survival and neuroprotection.
    L'episcopo F; Serapide MF; Tirolo C; Testa N; Caniglia S; Morale MC; Pluchino S; Marchetti B
    Mol Neurodegener; 2011 Jul; 6():49. PubMed ID: 21752258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural Stem Cell Grafts Promote Astroglia-Driven Neurorestoration in the Aged Parkinsonian Brain via Wnt/β-Catenin Signaling.
    L'Episcopo F; Tirolo C; Peruzzotti-Jametti L; Serapide MF; Testa N; Caniglia S; Balzarotti B; Pluchino S; Marchetti B
    Stem Cells; 2018 Aug; 36(8):1179-1197. PubMed ID: 29575325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Icariin attenuates neuroinflammation and exerts dopamine neuroprotection via an Nrf2-dependent manner.
    Zhang B; Wang G; He J; Yang Q; Li D; Li J; Zhang F
    J Neuroinflammation; 2019 Apr; 16(1):92. PubMed ID: 31010422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt/β-Catenin Signaling Pathway Governs a Full Program for Dopaminergic Neuron Survival, Neurorescue and Regeneration in the MPTP Mouse Model of Parkinson's Disease.
    Marchetti B
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30477246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Boosting Antioxidant Self-defenses by Grafting Astrocytes Rejuvenates the Aged Microenvironment and Mitigates Nigrostriatal Toxicity in Parkinsonian Brain
    Serapide MF; L'Episcopo F; Tirolo C; Testa N; Caniglia S; Giachino C; Marchetti B
    Front Aging Neurosci; 2020; 12():24. PubMed ID: 32226376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RGS Proteins as Critical Regulators of Motor Function and Their Implications in Parkinson's Disease.
    Ahlers-Dannen KE; Spicer MM; Fisher RA
    Mol Pharmacol; 2020 Dec; 98(6):730-738. PubMed ID: 32015009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiological Concentration of H
    Wang G; Yang Q; Zheng C; Li D; Li J; Zhang F
    Cell Mol Neurobiol; 2021 Jan; 41(1):163-171. PubMed ID: 32318898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ALCAR Exerts Neuroprotective and Pro-Neurogenic Effects by Inhibition of Glial Activation and Oxidative Stress via Activation of the Wnt/β-Catenin Signaling in Parkinsonian Rats.
    Singh S; Mishra A; Shukla S
    Mol Neurobiol; 2016 Sep; 53(7):4286-301. PubMed ID: 26223802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormones are key actors in gene x environment interactions programming the vulnerability to Parkinson's disease: glia as a common final pathway.
    Marchetti B; Serra PA; L'Episcopo F; Tirolo C; Caniglia S; Testa N; Cioni S; Gennuso F; Rocchitta G; Desole MS; Mazzarino MC; Miele E; Morale MC
    Ann N Y Acad Sci; 2005 Dec; 1057():296-318. PubMed ID: 16399902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axin-2 knockdown promote mitochondrial biogenesis and dopaminergic neurogenesis by regulating Wnt/β-catenin signaling in rat model of Parkinson's disease.
    Singh S; Mishra A; Mohanbhai SJ; Tiwari V; Chaturvedi RK; Khurana S; Shukla S
    Free Radic Biol Med; 2018 Dec; 129():73-87. PubMed ID: 30176346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactive astrocytes are key players in nigrostriatal dopaminergic neurorepair in the MPTP mouse model of Parkinson's disease: focus on endogenous neurorestoration.
    'Episcopo FL; Tirolo C; Testa N; Caniglia S; Morale MC; Marchetti B
    Curr Aging Sci; 2013 Feb; 6(1):45-55. PubMed ID: 23895521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons.
    Dragicevic E; Poetschke C; Duda J; Schlaudraff F; Lammel S; Schiemann J; Fauler M; Hetzel A; Watanabe M; Lujan R; Malenka RC; Striessnig J; Liss B
    Brain; 2014 Aug; 137(Pt 8):2287-302. PubMed ID: 24934288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Wnt signaling at the neuroimmune interface for dopaminergic neuroprotection/repair in Parkinson's disease.
    L'Episcopo F; Tirolo C; Caniglia S; Testa N; Morale MC; Serapide MF; Pluchino S; Marchetti B
    J Mol Cell Biol; 2014 Feb; 6(1):13-26. PubMed ID: 24431301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bruceine D elevates Nrf2 activation to restrain Parkinson's disease in mice through suppressing oxidative stress and inflammatory response.
    Yang Y; Kong F; Ding Q; Cai Y; Hao Y; Tang B
    Biochem Biophys Res Commun; 2020 Jun; 526(4):1013-1020. PubMed ID: 32321640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel Compound ITC-3 Activates the Nrf2 Signaling and Provides Neuroprotection in Parkinson's Disease Models.
    Lee JA; Son HJ; Park KD; Han SH; Shin N; Kim JH; Kim HR; Kim DJ; Hwang O
    Neurotox Res; 2015 Nov; 28(4):332-45. PubMed ID: 26233727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of a Novel Mouse Model of Parkinson's Disease via Targeted Knockdown of Glutamate Transporter GLT-1 in the Substantia Nigra.
    Zhang Y; Meng X; Jiao Z; Liu Y; Zhang X; Qu S
    ACS Chem Neurosci; 2020 Feb; 11(3):406-417. PubMed ID: 31909584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.